International Stem Cell CORP Research And Development Expense

• International Stem Cell CORP showed an increase of +4.1% in Research And Development Expense from 2024 to 2025.
• This data is from International Stem Cell CORP's annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), International Stem Cell CORP's Research And Development Expense has declined by 79.7%.
• Historical annual values: Fiscal year 2025: $684.0 thousand | Fiscal year 2024: $657.0 thousand | Fiscal year 2023: $511.0 thousand | Fiscal year 2022: $492.0 thousand | Fiscal year 2021: $695.0 thousand | Fiscal year 2020: $988.0 thousand | Fiscal year 2019: $1.39 million | Fiscal year 2018: $2.40 million | Fiscal year 2017: $2.66 million | Fiscal year 2016: $2.86 million | Fiscal year 2015: $2.71 million | Fiscal year 2014: $5.39 million | Fiscal year 2013: $3.56 million | Fiscal year 2012: $3.60 million | Fiscal year 2011: $4.43 million | Fiscal year 2010: $3.37 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026